Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company whose lead product candidate, eravacycline, is being developed as a broad-spectrum intravenous and oral antibiotic designed to be effective against dangerous, drug-resistant bacteria (including multidrug-resistant (MDR) Gram-negative pathogens), today announced that Guy Macdonald, Tetraphase President and Chief Executive Officer, will present at BioCentury’s 2014 NewsMakers in the Biotech Industry Conference on Friday, September 26th at 2:30 p.m. Eastern Time. The conference will take place at the Millennium Broadway Hotel in New York City.
Help employers find you! Check out all the jobs and post your resume.
